MONZA, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 5.672
EU - Europa 2.981
AS - Asia 1.575
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 3
SA - Sud America 2
Totale 10.246
Nazione #
US - Stati Uniti d'America 5.596
IT - Italia 769
DE - Germania 601
SG - Singapore 578
CN - Cina 576
SE - Svezia 449
IE - Irlanda 313
RU - Federazione Russa 302
GB - Regno Unito 160
HK - Hong Kong 117
VN - Vietnam 115
UA - Ucraina 93
CA - Canada 74
DK - Danimarca 69
IN - India 65
FR - Francia 57
TR - Turchia 44
FI - Finlandia 41
AT - Austria 29
ID - Indonesia 24
BE - Belgio 21
JP - Giappone 20
ES - Italia 17
NL - Olanda 17
KR - Corea 12
IR - Iran 10
CZ - Repubblica Ceca 9
AU - Australia 7
TW - Taiwan 7
HR - Croazia 6
EU - Europa 5
RO - Romania 5
CH - Svizzera 4
PL - Polonia 4
PT - Portogallo 4
RS - Serbia 4
BG - Bulgaria 3
SC - Seychelles 3
GT - Guatemala 2
AM - Armenia 1
BR - Brasile 1
CL - Cile 1
GR - Grecia 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SA - Arabia Saudita 1
Totale 10.246
Città #
Ann Arbor 1.890
Singapore 503
Frankfurt am Main 457
Wilmington 367
Chandler 358
Woodbridge 314
Milan 306
Dublin 303
Dearborn 246
Ashburn 244
Fairfield 213
Houston 180
New York 176
Santa Clara 146
Princeton 140
Hong Kong 114
Nanjing 114
Jacksonville 104
Seattle 93
Boardman 90
Cambridge 65
Shanghai 63
Guangzhou 57
Dong Ket 49
Nanchang 38
Lawrence 33
Altamura 32
Shenyang 30
Pune 29
Vienna 29
Hangzhou 27
Toronto 23
Beijing 22
Los Angeles 22
Ottawa 21
Shangdi 21
Zhengzhou 21
Helsinki 20
Rome 20
Andover 19
Fremont 19
Kunming 19
Brussels 18
Carate Brianza 18
Jakarta 18
San Diego 18
Dallas 17
Kocaeli 17
Sacramento 16
Falls Church 15
Tianjin 15
Jiaxing 14
Jinan 14
Edmonton 13
Hebei 13
Lachine 13
Changsha 12
Lissone 12
Mainz 12
Norwalk 12
Chicago 10
Codroipo 10
Florence 10
London 10
Melzo 10
Kiev 9
Elche 8
Sesto San Giovanni 8
Canazei 7
Hefei 7
Wuhan 7
Chengdu 6
Frederick 6
Grafing 6
Induno Olona 6
Romola 6
Taizhou 6
Tokyo 6
Bologna 5
Brno 5
Cagliari 5
Chandigarh 5
Council Bluffs 5
Falkenstein 5
Lanzhou 5
Merate 5
Ningbo 5
Paderno Dugnano 5
Pavia 5
Villeurbanne 5
Washington 5
Zagreb 5
Cislago 4
Duncan 4
Haikou 4
Lappeenranta 4
Laurel 4
Leawood 4
Lyon 4
Mumbai 4
Totale 7.544
Nome #
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized non-inferiority safety trial 307
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 298
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 235
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 222
Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI 220
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 217
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 216
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 208
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 208
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 204
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 204
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 199
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 197
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 196
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 195
In vitro models for studying oxaliplatin neurotoxic effects 186
Cerebral collateral therapeutics in acute ischemic stroke: A randomized preclinical trial of four modulation strategies 186
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 185
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 183
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 183
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 177
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 177
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 170
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 168
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 166
Incubation with low doses of oxaliplatin modifies the electrophysiological properties of dorsal root ganglion neurons 166
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 153
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 151
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 151
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 151
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 151
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 150
Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies 143
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 139
Thermal plantar test in experimental ischemic stroke 138
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 137
EMG Recordings at Rest to Verify Axonal Hyperexcitability in a Rat Model of Oxaliplatin Induced Peripheral Neurotoxicity 133
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 131
How to assess models of oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 130
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 130
Multimodal experimental approach to the study of human neurological diseases 129
Advanced neurophysiology - a translational approach to neuropathy and neuropathic pain 127
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 127
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 126
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 126
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 125
Cerebral collateral therapeutics in experimental ischemic stroke: a randomized preclinical trial of four modulation strategies 123
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 122
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 120
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 118
An in vitro model of dorsal root ganglion (DRG) neurons to investigate the molecular mechanisms of oxaliplatin-induced peripheral neuropathy. 117
Pharmacokinetics of IVIg in Wistar rats 115
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 111
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 109
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 102
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 102
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 100
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 98
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 97
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 96
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 96
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 96
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 95
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 94
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 93
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 92
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 90
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 80
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification 79
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 73
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 73
Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research 69
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 65
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 57
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN 52
Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118) 52
MITOCHONDRIAL DYSFUNCTION IS A FEATURE OF PACLITAXEL AND OXALIPLATIN-PROMOTED CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY 51
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 44
A mechanistic understanding of the relationship between skin innervation and chemotherapy-induced neuropathic pain 24
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 24
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 23
Selective Cerebrospinal Fluid Hypothermia: Bioengineering Development and In Vivo Study of an Intraventricular Cooling Device (V-COOL) 18
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 18
Head down tilt 15° to preserve salvageable brain tissue in acute ischemic stroke: A pre-clinical pooled analysis, with focus on cerebral hemodynamics 17
UNVEILING THE MICROVASCULAR NETWORK ALTERATIONS IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF RATS EXPOSED TO NEUROTOXIC CHEMOTHERAPY 17
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 16
Head Down Tilt 15° in Acute Ischemic Stroke with Poor Collaterals: A Randomized Preclinical Trial 14
Totale 11.073
Categoria #
all - tutte 37.482
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.482


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.088 0 0 0 0 132 216 239 106 117 148 110 20
2020/20212.161 48 59 222 210 155 226 249 254 179 160 161 238
2021/20221.207 122 164 133 116 84 96 60 54 49 63 84 182
2022/20231.828 198 362 223 187 155 304 58 84 120 31 64 42
2023/20241.293 56 46 59 76 144 292 191 75 63 32 40 219
2024/20251.437 163 470 343 160 301 0 0 0 0 0 0 0
Totale 11.073